164 related articles for article (PubMed ID: 12402832)
1. [Docetaxel in the adjuvant treatment of operable breast carcinoma. News from ASCO 2002].
Montemurro F
Tumori; 2002; 88(4):A1-7. PubMed ID: 12402832
[No Abstract] [Full Text] [Related]
2. Docetaxel in the treatment of breast cancer: an update on recent studies.
Nabholtz JM; Reese DM; Lindsay MA; Riva A
Semin Oncol; 2002 Jun; 29(3 Suppl 12):28-34. PubMed ID: 12170449
[TBL] [Abstract][Full Text] [Related]
3. 3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.
Ferreira Filho AF; Crown J; Cardoso F; Nogaret JM; Duffy K; Dolci S; Rowan S; O'Higgins N; Batter V; Paesmans M; Piccart MJ; Di Leo A
Anticancer Res; 2002; 22(4):2471-6. PubMed ID: 12174946
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for node-positive breast cancer patients: which is the reference today?
Fumoleau P; Bonneterre J; Luporsi E
J Clin Oncol; 2003 Mar; 21(6):1190-1; author reply 1191-2. PubMed ID: 12637489
[No Abstract] [Full Text] [Related]
5. Ongoing US cooperative group trials using taxanes in the adjuvant setting.
Davidson NE
Clin Breast Cancer; 2002 Oct; 3 Suppl 2():S53-8. PubMed ID: 12435293
[TBL] [Abstract][Full Text] [Related]
6. Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?
Valero V; Hortobagyi GN
J Clin Oncol; 2003 Mar; 21(6):959-62. PubMed ID: 12637456
[No Abstract] [Full Text] [Related]
7. [Docetaxel hydrate for treatment of advanced breast cancers].
Fujii H
Nihon Rinsho; 2000 Apr; 58 Suppl():254-8. PubMed ID: 11026003
[No Abstract] [Full Text] [Related]
8. A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.
Di Leo A; Crown J; Nogaret JM; Duffy K; Bartholomeus S; Dolci S; Rowan S; O'Higgins N; Paesmans M; Larsimont D; Riva A; Piccart MJ
Ann Oncol; 2000 Feb; 11(2):169-75. PubMed ID: 10761751
[TBL] [Abstract][Full Text] [Related]
9. [Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer].
Fattoruso SI; Rossi S; Vici P; Di Filippo F; Botti C; Di Lauro L; Foggi P; Saracca E; Ferranti FR; Visca P; Lopez M
Clin Ter; 2008; 159(6):443-7. PubMed ID: 19169606
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation during adjuvant chemotherapy with docetaxel: a case report.
Palma M; Mancuso A; Grifalchi F; Lugini A; Pizzardi N; Cortesi E
Tumori; 2002; 88(6):527-9. PubMed ID: 12597151
[TBL] [Abstract][Full Text] [Related]
11. Optimal chemotherapy for women with breast cancer: the plot thickens.
Pater JL; Pritchard KI
J Clin Oncol; 2003 Mar; 21(6):963-4. PubMed ID: 12637457
[No Abstract] [Full Text] [Related]
12. Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Francis P; Crown J; Di Leo A; Buyse M; Balil A; Andersson M; Nordenskjöld B; Lang I; Jakesz R; Vorobiof D; Gutiérrez J; van Hazel G; Dolci S; Jamin S; Bendahmane B; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Piccart-Gebhart M;
J Natl Cancer Inst; 2008 Jan; 100(2):121-33. PubMed ID: 18182617
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant docetaxel for node-positive breast cancer.
Martin M; Pienkowski T; Mackey J; Pawlicki M; Guastalla JP; Weaver C; Tomiak E; Al-Tweigeri T; Chap L; Juhos E; Guevin R; Howell A; Fornander T; Hainsworth J; Coleman R; Vinholes J; Modiano M; Pinter T; Tang SC; Colwell B; Prady C; Provencher L; Walde D; Rodriguez-Lescure A; Hugh J; Loret C; Rupin M; Blitz S; Jacobs P; Murawsky M; Riva A; Vogel C;
N Engl J Med; 2005 Jun; 352(22):2302-13. PubMed ID: 15930421
[TBL] [Abstract][Full Text] [Related]
14. [From conquering metastatic disease to adjuvant therapy: clinical evolution of docetaxel in breast cancer].
Cartenì G
Tumori; 2001; 87(6):A1-5. PubMed ID: 11995695
[No Abstract] [Full Text] [Related]
15. Expanding options in breast cancer.
Crown JP
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S19-24. PubMed ID: 10630364
[TBL] [Abstract][Full Text] [Related]
16. [A case of effective chemotherapy using CAF followed by docetaxel for advanced breast cancer].
Kokufu I; Taniguchi H; Kim YH; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H; Fukuda H
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1577-80. PubMed ID: 11016005
[TBL] [Abstract][Full Text] [Related]
17. The role of taxanes in the adjuvant treatment of early stage breast cancer.
Piccart M
Breast Cancer Res Treat; 2003; 79 Suppl 1():S25-34. PubMed ID: 12868803
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.
Nabholtz JM; Smylie M; Mackey JR; Noel D; Paterson AH; al-Tweigeri T; Au D; Sansregret E; Delorme F; Riva A
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):37-41. PubMed ID: 9364541
[TBL] [Abstract][Full Text] [Related]
19. A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer.
Crown J
Semin Oncol; 1999 Feb; 26(1 Suppl 3):5-9. PubMed ID: 10203264
[TBL] [Abstract][Full Text] [Related]
20. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]